Linden Thomas Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.64M Buy
37,469
+1,168
+3% +$54.1K 0.13% 263
2026
Q2
$1.55M Buy
36,301
+1,371
+4% +$74.4K 0.13% 281
2026
Q1
$2.19M Buy
+34,930
New +$2.79M 0.21% 165

Other funds holding BSX

Linden Thomas Advisory Services's BSX Position: Q3 2026 in Review

Linden Thomas Advisory Services increased its Boston Scientific (BSX) stake by 3.2% in Q3 2026, buying an estimated $54.1K and bringing the position to 37,469 shares worth $1.64M. The position accounts for 0.13% of the portfolio, ranked #263.

Linden Thomas Advisory Services first reported a position in BSX in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.19M in Q1 2026. 664 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Linden Thomas Advisory Services held 37,469 shares of Boston Scientific worth $1.64M as of Q3 2026.
  • Linden Thomas Advisory Services bought 1,168 Boston Scientific shares in Q3 2026, an estimated $54.1K.
  • Boston Scientific made up 0.13% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #263 holding.
  • Linden Thomas Advisory Services first reported a position in Boston Scientific in Q1 2026 and has held it in 3 quarters since.
  • Linden Thomas Advisory Services's Boston Scientific position peaked at $2.19M in Q1 2026.
  • 664 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.